SCHEMBL13115486

SCHEMBL13115486

COc1ccc(-c2nc(CC(=O)O)c(-c3cccs3)o2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.51
MAPT P10636 5/20 0.51
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
PKM P14618 1/20 0.51
ALDH1A1 P00352 4/20 0.48
HPGD P15428 2/20 0.48
ADCY1 Q08828 2/20 0.45
ADCY8 P40145 1/20 0.45
LMNA P02545 3/20 0.44
HSD17B10 Q99714 3/20 0.44
PDE10A Q9Y233 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
MEN1 O00255 2/20 0.43
RECQL P46063 1/20 0.43
F2 P00734 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
PTGDR2 Q9Y5Y4 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13232432 0.88 RAB9A (0.54) KDM4EMAPTNPC1RAB9AALDH1A1
SCHEMBL13115487 0.87 KDM4E (0.52) KDM4EMAPTNPC1RAB9AALDH1A1
SCHEMBL13115485 0.87 TARBP2 (0.48) KDM4EMAPTNPC1RAB9APKM
SCHEMBL13115597 0.85 KDM4E (0.47) KDM4EMAPTNPC1RAB9AALDH1A1
SCHEMBL11077690 0.85 RAB9A (0.48) KDM4EMAPTNPC1RAB9AALDH1A1
SCHEMBL13115880 0.84 KDM4E (0.46) KDM4EMAPTNPC1RAB9AALDH1A1
SCHEMBL13115606 0.84 KDM4E (0.49) KDM4EMAPTALDH1A1HPGDLMNA
SCHEMBL13116101 0.83 ALDH1A1 (0.46) KDM4EMAPTNPC1RAB9AALDH1A1
SCHEMBL13116100 0.83 KDM4E (0.44) KDM4EMAPTALDH1A1LMNASMN1; SMN2
SCHEMBL13116198 0.82 KDM4E (0.51) KDM4EMAPTNPC1RAB9APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER HONGU MITSUYA 2010-10-07 US disclosed
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER HONGU MITSUYA 2010-10-07 US disclosed
US-7759373-B2 Large conductance calcium-activated K channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-20 US disclosed
US-7759373-B2 Large conductance calcium-activated K channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER KCNN3, KCNN2, KCNN1 KDM4E 801/4885MAPT 2752/4885NPC1 1736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.